{"acute myeloid leukaemia": 34.17, "anaemia": 2.46, "colitis": 7.55, "cytomegalovirus infection reactivation": 44.28, "cytopenia": 22.52, "diffuse large b-cell lymphoma recurrent": 182.91, "disease progression": 16.4, "enteritis": 35.26, "febrile neutropenia": 38.16, "haematotoxicity": 75.0, "infection": 2.56, "mucosal inflammation": 33.8, "myelodysplastic syndrome": 61.03, "myelosuppression": 4.52, "neutropenia": 4.04, "neutrophil count decreased": 2.69, "non-hodgkin's lymphoma": 39.82, "non-hodgkin's lymphoma recurrent": 524.11, "off label use": 4.79, "pancytopenia": 9.06, "pneumonia": 2.4, "pneumonitis": 8.64, "product use in unapproved indication": 2.77, "product use issue": 2.06, "respiratory failure": 2.68, "second primary maligcy": 28.27, "sepsis": 4.35, "septic shock": 7.3, "stomatitis": 4.23, "thrombocytopenia": 8.41, "venoocclusive liver disease": 62.55}